Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.16M | 7.42M | 2.82M | 4.47M | 8.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.36M | 9.36M | 6.09M | 8.60M | 29.52M |
| Operating Income | -10.36M | -9.36M | -6.09M | -8.60M | -29.52M |
| Income Before Tax | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.37M | -9.44M | -5.88M | -9.66M | 11.26M |
| EBIT | -10.36M | -9.36M | -6.09M | -8.60M | -29.52M |
| EBITDA | -10.32M | -9.32M | -6.05M | -8.56M | -29.48M |
| EPS Basic | -0.07 | -0.09 | -0.03 | -0.04 | 0.08 |
| Normalized Basic EPS | -0.04 | -0.06 | -0.02 | -0.04 | -0.14 |
| EPS Diluted | -0.07 | -0.09 | -0.03 | -0.04 | -0.26 |
| Normalized Diluted EPS | -0.04 | -0.06 | -0.02 | -0.04 | -0.13 |
| Average Basic Shares Outstanding | 161.41M | 106.69M | 170.17M | 154.17M | 137.33M |
| Average Diluted Shares Outstanding | 161.41M | 106.69M | 170.17M | 154.17M | 142.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |